Hyundai Motor Co. will raise the ratio of electrified vehicles in global sales from the current 1.5 percent to 80 percent by 2040.
The company aims to initially raise the ratio of all-electric and hydrogen fuel-cell electric vehicles to 30 percent by 2030 and gradually replace its product lineup in Europe with hydrogen or battery-powered models by 2035 and in other major markets by 2040.
Hyundai plans to expand the hydrogen-powered vehicle lineup to three from the sole model Nexo, by adding a multi-purpose vehicle and a sport utility vehicle.
The automaker also plans to reduce its carbon emissions by 75 percent in 2014 from the 2019 levels and reach carbon neutrality in 2045.
Hyundai's hydrogen car sales jumped 44 percent to 5,300 units in the first seven months from 3,600 units a year earlier, surpassing those sold by Toyota Motor Corp.'s 4,100 and Honda Motor Co.'s 200 units.
Beginning 2025, Hyundai's independent Genesis brand will only sell hydrogen or battery-based models 2025 to meet changing market demand.
Hyundai's overall sales jumped 18 percent to 2.64 million vehicles in the January to August period, from 2.24 million units in the year-ago period.
The South Korean carmaker aims to boost its sales this year by 11 percent to 4.16 million vehicles from the 3.74 million units it sold last year.


Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off 



